Xuewei Yin

495 total citations
31 papers, 364 citations indexed

About

Xuewei Yin is a scholar working on Ophthalmology, Molecular Biology and Immunology. According to data from OpenAlex, Xuewei Yin has authored 31 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Ophthalmology, 12 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Xuewei Yin's work include Ocular Diseases and Behçet’s Syndrome (13 papers), interferon and immune responses (6 papers) and Systemic Lupus Erythematosus Research (6 papers). Xuewei Yin is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (13 papers), interferon and immune responses (6 papers) and Systemic Lupus Erythematosus Research (6 papers). Xuewei Yin collaborates with scholars based in China. Xuewei Yin's co-authors include Dadong Guo, Hongsheng Bi, Huixia Wei, Ruirong Xu, Shumin Ding, Ruiming Zhang, Lijie Guo, Bin Liu, Yuanyuan Sun and Shanshan Wu and has published in prestigious journals such as Scientific Reports, Archives of Biochemistry and Biophysics and European Journal of Pharmacology.

In The Last Decade

Xuewei Yin

26 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuewei Yin China 13 128 80 74 52 49 31 364
Xinying Hu China 10 123 1.0× 19 0.2× 29 0.4× 43 0.8× 77 1.6× 28 389
Guangming Wan China 9 87 0.7× 23 0.3× 92 1.2× 17 0.3× 52 1.1× 27 383
Shu Han China 15 292 2.3× 41 0.5× 14 0.2× 32 0.6× 48 1.0× 37 583
Mohammad Reza Ataollahi Iran 8 88 0.7× 52 0.7× 37 0.5× 32 0.6× 43 0.9× 16 343
Fangli Peng China 8 215 1.7× 49 0.6× 24 0.3× 15 0.3× 74 1.5× 15 443
Hyo‐Eun Yoon South Korea 15 171 1.3× 86 1.1× 15 0.2× 37 0.7× 60 1.2× 20 429
Xuelan Chen China 12 129 1.0× 87 1.1× 18 0.2× 48 0.9× 35 0.7× 38 413
Bo Qiu China 6 209 1.6× 23 0.3× 45 0.6× 32 0.6× 11 0.2× 8 400

Countries citing papers authored by Xuewei Yin

Since Specialization
Citations

This map shows the geographic impact of Xuewei Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuewei Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuewei Yin more than expected).

Fields of papers citing papers by Xuewei Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuewei Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuewei Yin. The network helps show where Xuewei Yin may publish in the future.

Co-authorship network of co-authors of Xuewei Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Xuewei Yin. A scholar is included among the top collaborators of Xuewei Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuewei Yin. Xuewei Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Xuewei, Huixia Wei, Xiuyan Zhang, et al.. (2025). MiR-30b-5p ameliorates experimental autoimmune uveitis by inhibiting the Atg5/Atg12/Becn1 Axis. International Immunopharmacology. 151. 114370–114370.
2.
3.
Yin, Xuewei, Qiang Li, Xiaochun Zhang, et al.. (2025). Paddy–Upland Rotation Improves Rice Growth and Reduces Greenhouse Gas Emissions in Winter Paddy Fields. Agronomy. 15(2). 349–349.
4.
Yin, Xuewei, Huixia Wei, Lijie Guo, et al.. (2025). Therapeutic effect of miR-30b-5p-loaded lentivirus on experimental autoimmune uveitis via inhibiting Notch signaling activation. Journal of Translational Medicine. 23(1). 426–426.
5.
Zhang, Miao, Zhiheng Li, Dadong Guo, et al.. (2025). Single-cell RNA sequencing reveals anterograde trans-synaptic degeneration and exacerbated synaptic remodeling in myopia. Experimental & Molecular Medicine. 57(7). 1536–1554.
6.
Yin, Xuewei, et al.. (2024). Vitamin D receptor gene polymorphisms and multiple myeloma: a meta-analysis. Clinical and Experimental Medicine. 24(1). 118–118. 2 indexed citations
8.
Yin, Xuewei, et al.. (2023). Prednisone acetate modulates Th1/Th2 and Th17/Treg cell homeostasis in experimental autoimmune uveitis via orchestrating the Notch signaling pathway. International Immunopharmacology. 116. 109809–109809. 14 indexed citations
9.
Xu, Shuqin, et al.. (2023). MiR-223-3p attenuates M1 macrophage polarization via suppressing the Notch signaling pathway and NLRP3-mediated pyroptosis in experimental autoimmune uveitis. European Journal of Pharmacology. 960. 176139–176139. 9 indexed citations
10.
Yin, Xuewei, Jingyi Wang, Shumin Ding, et al.. (2023). Zinc Oxide Nanoparticles Trigger Autophagy in the Human Multiple Myeloma Cell Line RPMI8226: an In Vitro Study. Biological Trace Element Research. 202(3). 913–926. 6 indexed citations
11.
Yin, Xuewei, et al.. (2023). Glucocorticoids improve the balance of M1/M2 macrophage polarization in experimental autoimmune uveitis through the P38MAPK-MEF2C axis. International Immunopharmacology. 120. 110392–110392. 12 indexed citations
12.
Yin, Xuewei, et al.. (2022). High Expression of ACOT2 Predicts Worse Overall Survival and Abnormal Lipid Metabolism: A Potential Target for Acute Myeloid Leukemia. Journal of Healthcare Engineering. 2022. 1–15. 3 indexed citations
13.
Yin, Xuewei, Lijie Guo, Huixia Wei, et al.. (2021). Longdan Xiegan Decoction alleviates experimental autoimmune uveitis in rats by inhibiting Notch signaling pathway activation and Th17 cell differentiation. Biomedicine & Pharmacotherapy. 136. 111291–111291. 13 indexed citations
14.
Guo, Dadong, et al.. (2021). Zinc oxide nanoparticle-triggered oxidative stress and autophagy activation in human tenon fibroblasts. European Journal of Pharmacology. 907. 174294–174294. 12 indexed citations
15.
Wang, Ling, Dadong Guo, Xuewei Yin, et al.. (2020). Zinc oxide nanoparticles induce human tenon fibroblast apoptosis through reactive oxygen species and caspase signaling pathway. Archives of Biochemistry and Biophysics. 683. 108324–108324. 21 indexed citations
16.
Guo, Dadong, et al.. (2020). Disrupted potassium ion homeostasis in ciliary muscle in negative lens-induced myopia in Guinea pigs. Archives of Biochemistry and Biophysics. 688. 108403–108403. 15 indexed citations
17.
Yin, Xuewei, Huixia Wei, Shanshan Wu, et al.. (2019). DAPT reverses the Th17/Treg imbalance in experimental autoimmune uveitis in vitro via inhibiting Notch signaling pathway. International Immunopharmacology. 79. 106107–106107. 20 indexed citations
18.
Yin, Xuewei, Qin Li, Huixia Wei, et al.. (2019). Zinc oxide nanoparticles ameliorate collagen lattice contraction in human tenon fibroblasts. Archives of Biochemistry and Biophysics. 669. 1–10. 12 indexed citations
19.
Guo, Dadong, Yuanyuan Sun, Junguo Guo, et al.. (2019). Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis. Nanotechnology. 30(16). 165702–165702. 24 indexed citations
20.
Yin, Xuewei, Bin Liu, Huixia Wei, et al.. (2019). Activation of the Notch signaling pathway disturbs the CD4+/CD8+, Th17/Treg balance in rats with experimental autoimmune uveitis. Inflammation Research. 68(9). 761–774. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026